Clinical Trial Update: Study of CM310 in Patients With Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating CM310 in allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• CM310

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED